Anlotinib Alleviates Renal Fibrosis via Inhibition of the ERK and AKT Signaling Pathways

por Sun, Donglin, Guo, Jing, Liang, Weifei, Chen, Yangxiao, Chen, Xiangqiu, Wang, Li
Publicado 2023

Serum RelB is correlated with renal fibrosis and predicts chronic kidney disease progression

por Sun, Donglin, Xie, Ningxia, Wang, Xi, Wu, Wenquan, Li, Xiu‐Yong, Chen, Xiangqiu, Qian, Guojun, Li, Cuifeng, Zhang, Haohao, Jiang, Yuhang, Ye, Deji, Liu, Dandan, Hu, Yiming, Wang, Jingyao, Chen, Weifeng, Zhao, Qiumei, Zeng, Min, Zhang, Junwei, Wang, Li, Zhang, Xiaoren
Publicado 2021